Enhanced Games Inside the Controversial Steroid Olympics Backed by Donald Trump Jr MidAmerica Apartment Communities Maintains Analyst Support Amid Price Target Adjustments Consumer Sentiment Plunges to Record Low in May as Iran Conflict Drives Gas Prices US Government Proposes 2 Billion in Quantum Computing Incentives Stocks Rally SpaceX Starship Test Could Influence Anticipated IPO Market Watchers Say Alberta Separation Referendum Sparks Economic Uncertainty Carney Highlights Provinces Essential Role AVNW Q1 2026 Earnings EPS Misses Estimates Sharply Stock Rises Despite Disappointment HWC Q1 2026 Earnings Modest EPS Beat Amid Stable Operating Environment BWB Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower BioRad Q1 2026 Earnings Earnings Miss Estimates Despite Stock Rally Moving iMage Technologies Inc MITQ Q1 2026 Earnings Net Loss Reported as Stock Edges Higher LKQ Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick Biomea Fusion BMEA Stages a Rebound Testing Key Resistance After a 365 Gain VirTra Inc VTSI Declines 187 as Shares Test Key Support Level Cornerstone Total Return Fund CRF Edges Higher as Income Appeal Drives Modest Gains Invest Green Acquisition Corporation IGAC Holds Steady at 998 Amid Neutral Trading BTCS Inc BTCS Slips 373 as Testing Key Support Levels Near 147 Federal Reserve Rate Cut Outlook Dims After Strong Jobs Report Circle Internet Group Inc CRCL Q1 2026 Earnings Slight EPS Beat in a Challenging Quarter BitFuFu FUFU Holds Near Support Amid Modest Decline MAXN Q4 2024 Earnings Significant EPS Beat Amidst Revenue Disclosure Gap FFWM Q4 2025 Earnings EPS Misses Estimates as Bank Faces Headwinds Shares Edge Higher Sera Prognostics Q1 2026 Earnings EPS Matches Estimates Stock Surges 15 on Strategic Progress GTN Q1 2026 Earnings Negative EPS Surprise Sends Shares Lower SMXT Q1 2026 Earnings Narrow Loss Reported with Minimal Stock Movement HE Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline